Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05302583 · ClinicalTrials.gov registry record · NA
Aromatherapy Inhaler Use for HSCT Distress
A NA study of Hematopoetic Stem Cell Transplant and Cancer Distress, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05302583: Recruiting NA study of Hematopoetic Stem Cell Transplant and Cancer Distress, sponsored by Stanford University.
NCT05302583 is a NA study of Hematopoetic Stem Cell Transplant and Cancer Distress that is actively recruiting participants, run by Stanford University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05302583, a NA study of Hematopoetic Stem Cell Transplant and Cancer Distress, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to evaluate aromatherapy inhaler use and how it may impact cancer distress and coping by patients in the first few days after hematopoietic stem cell transplant (HSCT).
Primary Outcome
Change in NCCN Distress Thermometer score (0-10 visual analog scale). Calculated as follow-up score minus baseline score.
Conditions Studied
Interventions
- OTHER Aromatherapy Inhaler
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-06-16 |
| Est. Completion | 2026-03 |
| Phase | NA |
What NCT05302583 shows while recruiting
NCT05302583 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 4 conditions, with Hematopoetic Stem Cell Transplant appearing as the primary indexed condition, and to 1 intervention - of which Aromatherapy Inhaler is the first listed.
NCT05302583 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05302583 about?
NCT05302583 is a clinical study titled "Aromatherapy Inhaler Use for HSCT Distress". The purpose of this research is to evaluate aromatherapy inhaler use and how it may impact cancer distress and coping by patients in the first few days after hematopoietic stem cell transplant (HSCT).
What is the current status of trial NCT05302583?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-06-16. Estimated completion is 2026-03.
What conditions does trial NCT05302583 study?
This clinical trial studies the following conditions: Hematopoetic Stem Cell Transplant, Cancer Distress, Cancer Coping, Aromatherapy.
What interventions are being tested in trial NCT05302583?
The interventions under investigation include: Aromatherapy Inhaler (OTHER).
Who is sponsoring clinical trial NCT05302583?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05302583 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematopoetic Stem Cell Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05302583's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI